Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
申请公布号
WO2006130174(A2)
申请公布日期
2006.12.07
申请号
WO2005US41275
申请日期
2005.11.16
申请人
MYLAN LABORATORIES, INC.;DAVIS, ERIC;O'DONNELL, JOHN;BOTTINI, PETER BRUCE;MASON, PRESTON;SHAW, ANDREW PRESTON
发明人
DAVIS, ERIC;O'DONNELL, JOHN;BOTTINI, PETER BRUCE;MASON, PRESTON;SHAW, ANDREW PRESTON